ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $427,000 | -57.3% | 50,000 | 0.0% | 0.38% | -42.0% |
Q3 2018 | $1,001,000 | -44.2% | 50,000 | -28.1% | 0.66% | -48.5% |
Q2 2018 | $1,795,000 | +103.1% | 69,500 | +87.8% | 1.27% | +89.3% |
Q1 2018 | $884,000 | -29.5% | 37,000 | 0.0% | 0.67% | -31.9% |
Q4 2017 | $1,254,000 | – | 37,000 | – | 0.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 657,467 | $2,709,000 | 2.82% |
Healthcare Value Capital, LLC | 100,000 | $412,000 | 1.36% |
Opaleye Management Inc. | 1,487,800 | $6,130,000 | 1.20% |
Worth Venture Partners, LLC | 225,106 | $927,000 | 0.76% |
ARMISTICE CAPITAL, LLC | 2,742,000 | $11,297,000 | 0.41% |
DELTEC ASSET MANAGEMENT LLC | 355,845 | $1,466,000 | 0.26% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 329,437 | $1,357,000 | 0.19% |
Mosaic Family Wealth, LLC | 92,357 | $381,000 | 0.14% |
EMERALD ADVISERS, LLC | 642,226 | $2,646,000 | 0.11% |
DCF Advisers, LLC | 31,236 | $129,000 | 0.07% |